LUCD — Lucid Diagnostics Balance Sheet
0.000.00%
- $42.73m
- $77.26m
- $2.43m
Annual balance sheet for Lucid Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.156 | 0.111 | 53.7 | 22.5 | 18.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 0.2 | 0.017 | 0.045 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.391 | 1.44 | 57.3 | 24.4 | 22.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | 0.971 | 3.6 | 2.64 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1.03 | 2.19 | 59 | 32.5 | 27.3 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.34 | 15.7 | 4.26 | 8.43 | 29.4 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.34 | 15.7 | 4.26 | 9.46 | 29.6 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -5.31 | -13.5 | 54.7 | 23 | -2.31 |
Total Liabilities & Shareholders' Equity | 1.03 | 2.19 | 59 | 32.5 | 27.3 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |